Faisal Abdulhamid Farrash, MD, MHCM 

Dr. Faisal Abdulhamid Farrash is
a distinguished neurosurgeon specializing in neuro-oncology at King Faisal Specialist Hospital & Research Centre (KFSH&RC) in Riyadh, Saudi Arabia. As the Director of the Neuro-Oncology Integrated Practice Unit and the Skull Base Fellowship Training Program, he leads advancements in treating complex brain tumors and skull base pathologies.

Board-certified in neurosurgery and fellowship trained in skull base surgery at the University of Toronto, Dr. Farrash possesses expertise in skull base and endoscopic surgery, complex spine surgery, peripheral nerve surgery, and neuro-oncology. He also has a Masters of Healthcare Management degree from McGill University.

His research interests include gene silencing techniques and the tumor microenvironment, significantly impacting neuro-oncological treatments. Dr. Farrash also champions integrating artificial intelligence in healthcare, emphasizing its potential to enhance diagnostics and personalize treatment strategies.

Jill Dietz, MD, MHCM, FACS

Jill Dietz is current CMO of Cyduct diagnostics, a company devoted to empowering women with personalized cancer risk assessment. Prior to that, as Chief Transformation Officer of the Cancer Institute and Director of Growth and Strategy for the Breast Program at Allegheny Health Network, Pittsburgh PA, she was the liaison between Highmark Health and the Cancer Institute and focused on establishing value-based initiatives, personalized cancer care delivery and the use of AI in cancer risk assessment. She completed her fellowship in breast surgery at the Cleveland Clinic, has practiced breast surgery for over 25 years, and led Breast Cancer programs at the Cleveland Clinic, Barnes Jewish Hospital and University Hospitals in Cleveland.

Dr Dietz received her Master’s in Health Care Management from Harvard School of Public Health. She is Principal of two consulting companies, TrueNorth Medical Consulting LLC, focusing on value-based transformation and Centers of Excellence guidance and Peace Medical Consulting LLC, an industry partner for education. Other corporate experience is consulting and advisory board positions with IceCure, Genomic Health and Flow Pharma.

Dr Dietz is the past President and Chairman of the Board of the American Society of Breast Surgeons (ASBrS) and Vice Chair of the National Accreditation Program for Breast Centers (NAPBC). Dr Dietz co-leads Global Breast Hub and serves as an advisor to Breast Global, international organizations with a mission to lessen gaps in breast cancer care around the world.

Dr Dietz led the multi-society Breast Cancer Pandemic Consortium to establish a prioritization recommendation, has taken part in international guideline and consensus statement development, has served as faculty in many courses, and is a frequent international invited speaker. Her current clinical and research interests include oncoplastic surgery, breast cancer risk assessment and stage shifting diagnosis, value-based and patient-centric care and the surgical techniques that promote such care delivery.

Nik Liolios

Nik is an AI data scientist and is a Product Manager at Google in Manhattan.  He was a co-founder of Tetra (sold to Atrium) and was featured in Forbes  “30 under 30” in Enterprise Technology.  Nik is a graduate of Phillips Exeter Academy and left Tufts to join Y-Combinator and found Tetra.  He is helping Flow Pharma’s bioinformatics team.